Imatinib Mesylate Treatment of Patients With Malignant Peripheral Nerve Sheath Tumors

NCT00427583 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
TERMINATED
Status
11
Enrollment
INDUSTRY
Sponsor class

Stopped stopped due to slow recruitment and no effect

Conditions

Interventions

Sponsor

Novartis Pharmaceuticals